Douglas E. Onsi - 01 Sep 2022 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Reporting relationship: CEO,CFO,Pres.,GC,Treas.,&Sec., Director
Issuer ticker: LPTX
Reported as of: 01 Sep 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Sep 2022, 21:25:05 UTC
Prior SEC filing: 02 Feb 2022
Next SEC filing: 21 Mar 2023
Source filing: View source filing
Reporting owner signature: /s/ Douglas E. Onsi

Key filing fact

Douglas E. Onsi filed Form 4 for LEAP THERAPEUTICS, INC. (LPTX) on 02 Sep 2022.

Key facts

This page summarizes Douglas E. Onsi's Form 4 filing for LEAP THERAPEUTICS, INC. (LPTX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Sep 2022, 21:25.

Change

Previous filing in this sequence was filed on 02 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LPTX transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +200,000
Change %
Price: $0.000000
Shares after: 200,000
Date: 01 Sep 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 200,000
Exercise price: $1.43
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Option was granted pursuant to Leap's 2022 Equity Incentive Plan and shall vest and become exercisable in a series of 36 equal monthly installments until the Option is fully vested, with the first such monthly installment vesting on the one month anniversary of September 1, 2022, the Vesting Start Date.